The forecast for diuretic medicine sales in Italy from 2024 to 2028 is stable, with the value constant at 2.2 US dollars per capita annually. This consistency follows a steady trend observed in 2023. Given the lack of annual variation, the year-on-year percentage change is 0%, leading to a zero compound annual growth rate (CAGR) over five years. Such a plateau suggests mature market dynamics in diuretic medicine consumption in Italy.
Future trends to watch for include:
- Potential policy changes affecting healthcare and pharmaceutical regulation.
- Demographic shifts, particularly in aging population segments.
- Innovations or entry of new medicines affecting consumer choice.
- Economic conditions influencing healthcare spending patterns.
